Skip to main content
  • Clinical Update

    Optimizing Outcomes With Toric IOLs

    By Annie Stuart, Contributing Writer, interviewing John Berdahl, MD, John A. Hovanesian, MD, and Sumitra S. Khandelwal, MD

    Download PDF

    Toric IOLs give many astigmatism patients a new lease on sight, making these lenses an attractive option for some cataract surgery pa­tients. For ophthalmologists, however, toric IOLs may pose challenges. Three cataract surgeons provide insight on achieving optimal results, discussing the importance of patient selection and offering pre-, intra-, and post-op pearls for avoiding potential pitfalls.

    Patient Selection

    Successful toric IOL outcomes depend in part on both patient education and selection.

    Educating patients. Before starting a conversation about the specifics of astigmatism correction, John A. Hova­nesian, MD, at Harvard Eye Associates in Laguna Hills, California, first asks his patients, “Have you been told you have astigmatism, and do you know what it is?” Starting with this basic question allows him to assess the patient’s level of knowledge so that he can properly tailor the conversation.

    As part of the discussion, it’s important to talk about the type of astigmatism patients have—regular or irreg­ular—and whether or not they are a good candidate for a toric lens, said Sumitra S. Khandelwal, MD, at Baylor College of Medicine–Cullen Eye Insti­tute in Houston.

    And John Berdahl, MD, at Vance Thompson Vision in Sioux Falls, South Dakota, eases into discussions about to­ric IOLs by telling patients this: “We’re going to fix your astigmatism—either with contact lenses, a Light Adjustable Lens, or an intraocular lens that fixes astigmatism during cataract surgery.” If the patient is properly educated and you know you can solve their problem, he added, they’re going to take their cues from you and relax.

    Candidates. Good candidates for toric IOLs are patients with regular astigmatism, consistent and repeatable corneal measurements, and a stable ocular surface, said Dr. Khandelwal. In addition, said Dr. Berdahl, ideal candi­dates have 1 D or more of astigmatism and would like to correct astigmatism during cataract surgery to decrease their dependence on glasses.

    Caution. “Be careful with patients who have changing vision or who have low amounts of astigmatism,” noted Dr. Khandelwal. “It may be difficult for you to meet their expectations.” In addition, she said, a toric lens may not be the best option for a patient with irregular astigmatism and may even make vision worse. This includes patients with very irregular keratoconus, corneal scars, or ocular surface disease, she said.

    Patients with irregular astigmatism should have a gas permeable contact lens over-refraction prior to cataract surgery, added Dr. Berdahl. “If the gas-permeable over-refraction shows no improvement in their vision, the corneal irregularity is not contributing to their decreased vision and a toric lens may make sense. Conversely, if the gas-permeable over-refraction does show improvement, the corneal irregularity is a part of their decreased vision and a toric probably should be avoided.”

    Refractive surgery. Also, said Dr. Berdahl, patients who’ve had prior refractive surgery present a challenge, in part, because it’s more difficult to get accurate biometric readings. “Plan carefully. Be sure to also account for posterior astigmatism so you don’t induce unnecessary astigmatism. To do so, compare manifest refraction to biometry, measure posterior corneal curvature, or use intraoperative aber­rometry.”

    Preoperative Procedures

    Implant a toric lens only if you’re con­fident that you’ve obtained measure­ments that are repeatable and that agree with each other, said Dr. Khandelwal. Prior to surgery, Dr. Khandelwal gets measurements on two different days. “I use topography when I see the patient for the first time.” Later, she said, “at the pre-op visit, I do both biometry and topography, which should match the first topography measurement. I then look at the magnitude and axis for all my measurements, as well as the patient’s refraction, to determine the lens.”

    Topography. For the initial cataract evaluation, Dr. Khandelwal likes using Placido disc–based topography to pho­tographically map the curvature of the cornea. “Placido imaging gives magni­tude and axis but also shows rings that correlate with the cornea,” she said. “I point out any irregular rings or missing data, educating the patient about signs of an irregular cornea.”

    If the pattern is a fairly symmetri­cal bow tie, a toric lens should work well, said Dr. Hovanesian. “But if it’s off center—a bow tie with skewed radial axes and other evidence of a higher-order aberration—I show this to the patient and note that I likely won’t be able to fully correct their irregular astigmatism.”

    Biometry. Optical biometers measure the length of the eye, curve and width of the cornea, and ante­rior chamber depth. Optical biome­ters—such as Argos (Alcon), Lenstar (Haag-Streit), and IOLMaster (Zeiss)—usually provide “a fairly accurate read on the magnitude of astigmatism. Although corneal topography tends to be the best measure of the axis of the astigmatism, most cataract special­ists use optical biometry and double-check it against corneal topography,” Dr. Hovanesian said.

    Digital planning systems. Dr. Hov­anesian finds it helpful to use a digital planning system such as SmartCataract (Alcon) or Veracity Surgical (Zeiss). “It interfaces with optical biometry, automating calculations, improving accuracy, saving time, and reducing costs. It automatically applies the most modern formulas, giving the surgeon reliable calculations with no risk of transcription error that occurs with other online calculators.”

    Before surgery. To get the best surgical results, Dr. Khandelwal said, patients should stop wearing toric contact lenses for several weeks before cataract surgery.

    If you have a patient with a treatable condition that is causing astigmatism or irregularity, such as Salzmann nodular degeneration or a pterygium, treat it and let it heal for a couple of months before cataract surgery, said Dr. Hov­anesian. “Then, reassess what type of correction is best for this patient.”

    Intraoperative Alignment

    During the procedure, the surgeon can choose from an array of tools that may help achieve optimal results.

    Aberrometry. An intraoperative ab­errometer such as Optiwave Refractive Analysis (ORA; Alcon) takes phakic, aphakic, and pseudophakic refractive measurements in the operating room, which allows the surgeon to determine whether the lens is positioned correctly. This can improve accuracy, especially in patients for whom getting good pre-op measurements are challenging, such as those who’ve had prior refractive surgery, said Dr. Hovanesian.

    Marking. Some surgeons use ocular blood vessels as reference points, said Dr. Berdahl. “Called fingerprinting, this allows a proper reference for the IOL, whether the patient is sitting or lying down.” This technique can be support­ed by image-guided systems, such as Verion (Alcon) and Callisto Eye (Zeiss), which capture a preoperative refer­ence image and intraoperative image registration using limbal landmarks to match the two images, he said.

    Marking can also be done manually, which usually produces results consis­tent with image-guided systems, said Dr. Khandelwal. “The image-guided system avoids problems with the mark washing off or being of poor quality,” she said. “But you never know when a machine will have challenges, so I always manually mark the patients as a backup.” Dr. Berdahl also uses manual marking as a fail-safe. “If I can’t get an accurate intraoperative aberrome­try reading, the six o’clock mark is the backup reference point.”

    IOL positioning. To ensure good positioning, Dr. Khandelwal advises putting the hash marks on the toric IOL in the alignment of the axis and then completely removing the viscoelastic, including behind the IOL. “Make sure the chamber doesn’t com­pletely shallow, and check the lens one more time before you end the surgery,” she said. “Sometimes the lens will rotate a little bit more after the viscoelastic is removed, in which case it’s important to take the time to rotate it all the way around.”

    Other steps to take? “Just do a good cataract surgery with a nice, round capsulotomy that overlaps the IOL 360 degrees,” said Dr. Berdahl. “Be sure you don’t induce a lot of astig­matism with your incision or corneal edema with your surgery. Make sure wounds are well sealed with no small leaks. And when you take out the lid speculum, check that the IOL hasn’t shifted.”

    Light Adjustable Lens and IC-8 Apthera

    “Even with the best preoperative measurements and the best intraop­erative technique, you may still get astigmatism refractive surprises with certain patients,” said Dr. Khandel­wal. “Is it because of the posterior cornea? Is it because of lens tilt? Is it because of something else we just don’t know about? That’s why we’re all looking forward to the day when that never happens because we’re able to do something outside the box.” In the meantime, other alterna­tives are available, such as the Light Adjustable Lens (RxSight) and IC-8 Apthera (AcuFocus).

    Light Adjustable Lens. Approved roughly two years ago, the Light Adjustable Lens is made of silicone with an electromagnetic coating, said Dr. Berdahl. “We insert it in the eye at the time of cataract surgery. The pa­tient returns three weeks later, when we shine an ultraviolet light on their eye to change the shape of the lens and fix the astigmatism and residual spherical error.”

    Dr. Berdahl’s practice uses this lens nearly exclusively for patients with astigmatism—except in cases where the pupil is too small for light delivery or there’s concern about photosensitizing medication.

    Although Dr. Hovanesian uses this lens much less often than Dr. Berdahl, he recommends it for patients with slightly irregular corneas or who’ve had prior refractive surgery. “It gives the most precise correction of astig­matism that I have seen,” he added. “Studies show that it can achieve up to about 2.5 D of astigmatism correc­tion. But this lens requires additional expense and effort, given that more than one visit is needed after surgery to adjust the lens.”

    IC-8 small aperture lens. The IC-8 Apthera was approved on July 25, 2022. Dr. Hovanesian finds this small aperture IOL unique among astig­matism-correcting lenses because it is designed to correct up to 1.5 D of astigmatism. “It doesn’t matter what axis you put it at. The only thing that matters is the sphere power. Typi­cally, we aim for about –1 D with this lens. Because there’s a nice pinhole, the patient can get not only astig­matism correction and correction of higher order aberrations but also very acceptable distance and near vision.”

    Postoperative Problem-Solving

    After cataract surgery, patients with astigmatism are often able to go with­out glasses, said Dr. Berdahl. However, toric lenses can rotate, leaving the patient somewhat astigmatic, he said.

    Residual astigmatism. To set expec­tations, Dr. Khandelwal tells patients that fewer than 5% of patients need further corrections or adjustments after cataract surgery to correct residual astigmatism. Dr. Berdahl quotes a slightly higher percentage, and given a multi­tude of cases, he said, the total num­ber adds up. “We usually do a LASIK enhancement for residual astigmatism,” said Dr. Berdahl. Dr. Khandelwal agrees that it is wise to err on the side of not going back inside the eye to make adjustments.

    Rotation. About rotation, Dr. Khan­delwal said that there have been instanc­es in which “we put a hash mark on the cornea that matches the lens implant and it’s been perfectly aligned at the end of surgery, but the lens then rotates after surgery.” Studies have shown that if the lens rotates, it does so within a few hours of surgery, she said. She added that studies have suggested the optimal time to correct the rotated lens is usu­ally one to three weeks after surgery. “If you do this too early, the lens may just rotate again.”

    In cases with residual astigmatism, Dr. Berdahl said, “We have found that about 72% of the time, residual astig­matism is present because the intended axis was not the ideal axis. We also found that the IOL rotated about 75% of the time.”

    Outcomes analysis. “I believe the vast majority of surgeons don’t do outcomes analysis because it’s a bit of a heavy lift,” said Dr. Berdahl. His prac­tice uses local premed college students to enter, analyze, and present the data to the surgeons.

    Toric results analyzer. Whenever you do a toric IOL surgery, you should have a plan to address remaining astig­matism if the patient is unsatisfied, said Dr. Berdahl. “You may need to do an IOL exchange, an IOL rotation, or laser vision correction afterward. A number of calculators are available to help you with this planning.”

    Dr. Berdahl and colleagues created a free online resource called Toric Results Analyzer (astigmatismfix.com). Using the patient’s postoperative manifest refraction, power, and the IOL’s current axis, the calculator helps predict the ideal position of the toric IOL to minimize the patient’s residu­al astigmatism, said Dr. Berdahl. Dr. Khandelwal added that this calculator helps her decide whether rotation or another approach is the best option for correcting residual astigmatism.

    ___________________________

    Dr. Berdahl is partner at Vance Thompson Vision in Sioux Falls, S.D. Relevant financial disclosures: Alcon: C,L; Bausch + Lomb: C; Johnson and John­son: C; RxSight: C.

    Dr. Hovanesian is principal at Harvard Eye Asso­ciates in Laguna Hills, Calif., and clinical assistant professor at the University of California, Los An­geles Jules Stein Eye Institute. Relevant financial disclosures: AcuFocus: C; Alcon: C,L,O,S; Bausch + Lomb: C,L,S; Carl Zeiss Meditec: C,L,S; Johnson and Johnson Vision: C,L,O,S; RxSight: C,O.

    Dr. Khandelwal is associate professor of ophthal­mology at Baylor College of Medicine–Cullen Eye Institute in Houston. Relevant financial disclosures: Alcon: C; Bausch + Lomb: C; Carl Zeiss Meditec: C.

    For full disclosures and the disclosure key, see below.

    Full Financial Disclosures

    Dr. Berdahl AbbVie: C,L; Aerie: C; Aerpio: C; Alcon: C,L; Aldeyra: C; Aurea Medical: C; Bausch + Lomb: C; CorneaGen: C,O; Dakota Lions Eye Bank: C; Equinox: C,O; Expert Opinion: C,O; Glaukos: C,L; Gore: C; Imprimis: C,P; iRenix: C; Lacta Pharma­ceuticals: C; JNJ: C; Kala: C; Kedalion: C; Melt Pharmaceuticals: C: MicroOptx: C; New World Medical: C; Ocular Surgical Data: C,O; Ocular Therapeutix: C; Omega Ophthalmic: C,O; Orasis: C; Oyster Point: C; RxSight: C; Sight Sciences: C; Surface Inc: C,O; Tarsus: C; Tear Clear: C; Vertex Ven­tures: C; ViaLase: C; Vittamed: C; Vance Thompson Vision: C,O; Verana Health: O; Visionary Ventures: C; Visus: C; Zeiss: C,O.

    Dr. Hovanesian AcuFocus: C; Aerie: C; Alcon Laboratories: C,L,O,S; Alicia Surgery Center: O; Allegro Ophthalmics: C,O; Allergan: C,O; Avellino Labs: C; Azura Ophthalmics: C; Bausch + Lomb Surgical: C,L,S; Bausch + Lomb: C,L,S; BlephEx: C,L,O; Carl Zeiss Meditec: C,L,S; Cloud­break Therapeutix: C,O; Cord: C,L,O; ECRI: C; Equinox: C,O; Eyedetec: C,L,O; Eye­Point: C,L,S; Glaukos: C,L; GlaxoSmith­Kline: C; Gobiquity: C,O; Guardion Health Sciences: C,O; Harvard Eye Associates: O; Ingenoeye: C,O; Ivantis: C; Johnson & Johnson Vision: C,L,O,S; Kala Pharmaceu­ticals: C; Katena Products, Inc: C,L; MD­backline: O,P; Novaliq: C; Novartis, Alcon Pharmaceuticals: C,O,S; Ocular Therapeu­tix: C,L,O; Oculus: C; Omeros: C,L; On Point Vision: C,P; Orasis: C,O; Reata: C,S; Re­focus Group: C; Research InSight: O; Re­Vision Optics: C; RxSight: C,O; Sarentis Ophthalmics: C,O; Shire: C,L,S; Sight Sci­ences: C,O;SightLife: C,O; Slack: C,L; Sun Ophthalmics: C,L,S; Tear Clear: C,O; Tear­Lab Corporation: C,L; Versant Ventures: O; Vindico Medical Education: C,L; Vision­ary Ventures Fund 1 and 2 & its invest­ments: O; Vista Research: C; Visus: C.

    Dr. Khandelwal Alcon: C; Bausch + Lomb: C; Carl Zeiss Meditec: C; Dompe: C; Kala: C; Ocular Therapeutix: C.

    Disclosure Category

    Code

    Description

    Consultant/Advisor C Consultant fee, paid advisory boards, or fees for attending a meeting.
    Employee E Hired to work for compensation or received a W2 from a company.
    Employee, executive role EE Hired to work in an executive role for compensation or received a W2 from a company.
    Owner of company EO Ownership or controlling interest in a company, other than stock.
    Independent contractor I Contracted work, including contracted research.
    Lecture fees/Speakers bureau L Lecture fees or honoraria, travel fees or reimbursements when speaking at the invitation of a commercial company.
    Patents/Royalty P Beneficiary of patents and/or royalties for intellectual property.
    Equity/Stock/Stock options holder, private corporation PS Equity ownership, stock and/or stock options in privately owned firms, excluding mutual funds.
    Grant support S Grant support or other financial support from all sources, including research support from government agencies (e.g., NIH), foundations, device manufacturers, and\or pharmaceutical companies. Research funding should be disclosed by the principal or named investigator even if your institution receives the grant and manages the funds.
    Stock options, public or private corporation SO Stock options in a public or private company.
    Equity/Stock holder, public corporation US Equity ownership or stock in publicly traded firms, excluding mutual funds (listed on the stock exchange).